EDGAR ENGLEMAN - Director at Bolt Biotherapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
BOLT on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by EDGAR ENGLEMAN since 11 Jan 2025

Holdings reported by EDGAR ENGLEMAN for Bolt Biotherapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1,821,483 $1,730,409 $0.9500 30 Nov 2023 By Vivo Capital Fund VIII, L.P.
Common Stock 251,522 $238,946 $0.9500 30 Nov 2023 By Vivo Capital Surplus Fund VIII, L.P.
Stock Option (Right to Buy) 25,000 12 Jun 2023 Direct Common Stock

Transactions reported by EDGAR ENGLEMAN for Bolt Biotherapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.